Skip to main content
Premium Trial:

Request an Annual Quote

LGC Buys Fluidigm BioMark System

NEW YORK (GenomeWeb News) — Fluidigm said today that lab services company LGC has purchased a BioMark System for use in its genetic analysis labs in the United Kingdom.

LGC will use the system to enhance its services including digital PCR and gene expression opportunities in its Research & Technology Division. The UK firm also plans to use the system across its other three divisions: LGC Standards, Life & Food Sciences, and LGC Forensics.

Derek Cranston, who directs LGC's R&T division, said in a statement that the company will first "look at the accurate quantification of rare target sequences for applications such as health diagnostics and monitoring the efficiency of drug therapies."

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.